Indeed, chlorogenic acid has anti-diabetic and anti-obesity properties by reducing glucose absorption in the small intestine through inhibition of the enzyme glucose-6-phosphate translocase, inhibiting the hepatic enzyme glucose-6-phosphatase, and increasing phosphorylation of AMP-activated protein kinase [46,47]. This evidence concerns the gene G6PC1 and obesity due to melanocortin 4 receptor deficiency.